Tyrogenex

About:

Tyrogenex is a biotechnology company researching and developing treatments for solid tumors.

Top Investors: Brace Pharma

Description:

Tyrogenex, Inc., a biotechnology company, engages in research and development of multi-kinase angiogenesis inhibitor for the treatment of solid tumors. The company has developed a novel, patented cancer therapeutic, X-82, a dual VEGFR/PDGFR inhibitor. The company was formerly known as Xcovery, Inc. The company was incorporated in 2006 and is based in West Palm Beach, Florida. The company operates as a subsidiary of Xcovery LLC.

Total Funding Amount:

$21.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

West Palm Beach, Florida, United States

Founded Date:

2006-01-01

Founders:

Sheridan Snyder

Number of Employees:

1-10

Last Funding Date:

2016-02-26

IPO Status:

Private

Industries: